In the preceding three months, 16 analysts have released ratings for Universal Health Servs UHS, presenting a wide array of perspectives from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 3 | 3 | 6 | 4 | 0 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 1 | 2 | 3 | 1 | 0 |
| 2M Ago | 0 | 1 | 1 | 3 | 0 |
| 3M Ago | 1 | 0 | 2 | 0 | 0 |
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $208.62, along with a high estimate of $267.00 and a low estimate of $162.00. Surpassing the previous average price target of $186.40, the current average has increased by 11.92%.
Exploring Analyst Ratings: An In-Depth Overview
The analysis of recent analyst actions sheds light on the perception of Universal Health Servs by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| A.J. Rice | UBS | Raises | Buy | $267.00 | $247.00 |
| Jamie Perse | Goldman Sachs | Raises | Buy | $229.00 | $200.00 |
| Stephen Baxter | Wells Fargo | Raises | Overweight | $255.00 | $200.00 |
| Gary Taylor | TD Cowen | Raises | Hold | $220.00 | $183.00 |
| Sarah James | Cantor Fitzgerald | Raises | Neutral | $219.00 | $162.00 |
| Andrew Mok | Barclays | Raises | Overweight | $256.00 | $198.00 |
| Scott Fidel | Stephens & Co. | Maintains | Equal-Weight | $200.00 | $200.00 |
| Sarah James | Cantor Fitzgerald | Maintains | Underweight | $162.00 | $162.00 |
| Andrew Mok | Barclays | Raises | Equal-Weight | $198.00 | $189.00 |
| Sarah James | Cantor Fitzgerald | Maintains | Underweight | $162.00 | $162.00 |
| Sarah James | Cantor Fitzgerald | Maintains | Underweight | $162.00 | $162.00 |
| Sarah James | Cantor Fitzgerald | Maintains | Underweight | $162.00 | $162.00 |
| Michael Ha | Baird | Raises | Outperform | $236.00 | $198.00 |
| Lisa Gill | JP Morgan | Raises | Neutral | $186.00 | $182.00 |
| Michael Ha | Baird | Announces | Neutral | $198.00 | - |
| A.J. Rice | UBS | Raises | Buy | $226.00 | $189.00 |
Key Insights:
- Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Universal Health Servs. This offers insight into analysts' perspectives on the current state of the company.
- Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Universal Health Servs compared to the broader market.
- Price Targets: Delving into movements, analysts provide estimates for the future value of Universal Health Servs's stock. This analysis reveals shifts in analysts' expectations over time.
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Universal Health Servs's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
Stay up to date on Universal Health Servs analyst ratings.
Unveiling the Story Behind Universal Health Servs
Universal Health Services Inc owns and operates acute care hospitals, behavior health centers, surgical hospitals, ambulatory surgery centers, and radiation oncology centers. The firm operates in two key segments: Acute Care Hospital Services and Behavioral Health Services. The Acute Care Hospital Services segment includes the firm's acute care hospitals, surgical hospitals, and surgery and oncology centers.
Universal Health Servs's Economic Impact: An Analysis
Market Capitalization Highlights: Above the industry average, the company's market capitalization signifies a significant scale, indicating strong confidence and market prominence.
Positive Revenue Trend: Examining Universal Health Servs's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 10.13% as of 30 June, 2024, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Health Care sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 7.4%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Universal Health Servs's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 4.54%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Universal Health Servs's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 2.06%, the company showcases efficient use of assets and strong financial health.
Debt Management: Universal Health Servs's debt-to-equity ratio is below the industry average. With a ratio of 0.77, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
The Core of Analyst Ratings: What Every Investor Should Know
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in Benzinga Pro.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
